challenges in treating tp53-mutated aml, hope on the horizon
Published 1 year ago • 165 plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
1:53
challenges in treating patients with tp53-mutated aml and future outlooks
-
2:24
the challenges of treating tp53-mutated aml and mds
-
2:42
challenges in treating patients with tp53-mutated mcl & promising novel therapies being explored
-
1:56
dr. pemmaraju on the challenges of targeting tp53 mutations in mds/aml
-
1:39
treatment approaches for patients with tp53m aml ineligible for high intensity chemotherapy
-
1:40
outcomes of allohsct in tp53-mutated aml and mds
-
2:27
addressing the unmet needs for patients with tp53-mutated aml
-
1:13
the challenges of treating patients with mpns who possess a tp53 mutation
-
1:27
treatment options for patients with tp53-mutated aml
-
1:57
tolerability and efficacy of magrolimab plus azacitidine in tp53-mutated aml patients
-
1:57
the benefit of allogeneic transplantation in patients with tp53-mutated aml
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
3:22
is tp53-mutated high-risk mds the same disease as tp53-mutated aml?
-
5:16
an analysis of tp53 mutation in aml and hr-mds
-
0:41
promising agents in aml: menin inhibitors & magrolimab in tp53-mutated aml
-
1:08
novel strategies to target p53-mutant hematological malignancies
-
23:04
tp53-mutant aml: a pathology-guided journey through diagnostic principles
-
1:38
the importance of targeting tp53 in aml and agents being explored
-
3:39
the association between prior exposure to lenalidomide and tp53-mutated aml/mds